In which clinical situations is pulmonary artery diastolic pressure not a reliable surrogate for left‑ventricular end‑diastolic pressure, and why?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When PAD is Not Reflective of LVEDP

Pulmonary artery diastolic pressure (PAD) should not be used as a surrogate for LVEDP in two critical scenarios: when pulmonary vascular resistance is significantly elevated, or when cardiac output is markedly increased (either through tachycardia causing shortened diastole or high stroke volume causing catheter whip). 1

Primary Technical and Hemodynamic Limitations

High Cardiac Output States

PAD becomes unreliable when:

  • Tachycardia shortens diastolic time, preventing pressure equilibration between the pulmonary artery and left atrium
  • Increased stroke volume causes catheter whip artifact, making accurate pressure measurement impossible 1

Elevated Pulmonary Vascular Resistance

When PVR is significantly elevated, a pressure gradient develops across the pulmonary vascular bed that persists throughout diastole, preventing PAD from reflecting downstream left-sided pressures 1.

Clinical Conditions Where PAWP/LVEDP Discordance Occurs

When PAWP > LVEDP (Overestimates LVEDP)

The most recent 2025 Chest guidelines identify specific conditions where wedge pressure exceeds true LVEDP 1:

  • Atrial fibrillation - loss of coordinated atrial contraction disrupts normal pressure relationships
  • Valvular disease: mitral stenosis, mitral regurgitation (large V-waves), pulmonic stenosis
  • Left atrial myxoma - mechanical obstruction
  • Pulmonary veno-occlusive disease - downstream obstruction from balloon occlusion site
  • Large left atrial diameter - altered compliance characteristics
  • Pulmonary venous obstruction (intrinsic or extrinsic) - PAWP reflects obstruction site rather than LA pressure

Critical caveat: In mitral regurgitation, large V-waves are typically excluded from PAWP calculation to estimate LVEDP accurately, though including them may better reflect actual pulmonary venous hypertension burden 1.

When PAWP < LVEDP (Underestimates LVEDP)

These conditions cause LVEDP to exceed LA pressure 1:

  • Decreased LV compliance - stiff ventricle requires higher filling pressure
  • Older age - age-related changes in ventricular compliance
  • Severe LV hypertrophy - even with normally functioning valves, LVEDP exceeds LA pressure
  • Severe aortic regurgitation - retrograde aortic filling causes premature mitral valve closure, isolating the LV from LA during end-diastole

The mechanism in aortic insufficiency is particularly important: Rapid retrograde filling from the aorta causes the mitral valve to close before end-diastole, preventing pressure equilibration between the LV and LA 1.

Right Ventricular Cardiogenic Shock

Recent 2024 data demonstrates that in right ventricular-predominant cardiogenic shock, the correlation between PAD and PCWP is weak (r = 0.43), making PAD an unreliable surrogate in this specific phenotype 2. This contrasts with left ventricular, biventricular, and other CS phenotypes where correlation remains moderate to strong (r = 0.64 overall).

Practical Measurement Considerations

Optimal PAD Measurement Timing

When PAD must be used, measure at 0.08 seconds after QRS onset rather than at the lowest point on the waveform for best LVEDP correlation (r = 0.88 vs r = 0.82) 3.

When Direct LVEDP Measurement is Preferred

The 2025 guidelines explicitly state: "Measurement of LVEDP is preferred to dPAP when PAWP cannot be obtained" 1. This is particularly important when:

  • PAWP cannot be reliably obtained
  • Clinical suspicion exists for conditions causing PAWP-LVEDP discordance
  • Precise hemodynamic assessment is critical for treatment decisions

Interstitial Lung Disease Considerations

In ILD patients, PAWP-LVEDP discordance occurs in approximately 10% of cases, with left atrial dysfunction (PAWP-LVEDP difference >3 mmHg) present in 14% 4. This can alter PVR calculations and potentially change treatment targets for PH-specific therapy in up to 22% of patients.

Common Pitfalls to Avoid

  1. Never assume PAD = LVEDP in tachycardia - shortened diastole prevents equilibration
  2. Recognize that "normal" PAWP after diuresis may be falsely reassuring in patients with LV diastolic dysfunction 5, 6
  3. Don't rely on PAD in known elevated PVR states - the gradient persists throughout diastole
  4. In mitral regurgitation, understand whether you're estimating LVEDP (exclude V-waves) or assessing pulmonary venous burden (include V-waves) 1
  5. Consider direct LVEDP measurement in elderly patients with LVH even when PAWP appears normal

Related Questions

How is pulmonary artery end-diastolic pressure estimated using transthoracic echocardiography?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
Do hepatic cysts require work‑up?
What is the best treatment strategy for a 58-year-old woman with newly diagnosed post‑traumatic stress disorder (PTSD) presenting with nightmares, severe anxiety with panic attacks, and severe angry outbursts?
Can you interpret the imaging findings for a 61‑year‑old patient, which show no acute fracture, maintained vertebral body height, no significant degenerative changes, normal disc spaces, unremarkable soft tissues, and clear visualized lung fields?
Can Cobenfy (xanomeline/trospium) be taken once daily if severe nausea occurs?
For a patient with a minimally displaced subcapital femoral neck fracture, should they be discharged from the emergency department for outpatient orthopedic follow‑up, or admitted for definitive orthopedic evaluation and treatment?
Can TheraHoney (medical‑grade honey) be used to treat a superficial (first‑degree or superficial second‑degree) burn?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.